drugset / Trial / NCT00708240

Treatment Youth With Obsessive-Compulsive Disorder

NCT00708240

Phase 4 Unknown 40 enrolled University of Ottawa H. Lundbeck A/S · collab
NaSingle-groupOpen-labelTreatment

Summary

Although research suggests that patients with obsessive-compulsive disorder (OCD) exhibit specific deficits in their high cognitive processes, it is still unknown how these deficits relate to the clinical symptoms of the disorder, and to the response to treatment. There are two aims for the proposed research. The first is to examine how high cognitive processes and brain activity are affected in OCD. The second aim is to investigate the effects of a specific psychotropic medication (escitalopram) on high cognitive processes and brain activity in OCD. We will investigate how 40 youth with OCD (recruited in specialized clinics) differ from 40 healthy youth (recruited from the local community) on selected cognitive tests and brain imaging paradigms, as well as explore how treatment with medication can correct or reverse the observed differences. The final goal of our research is to learn more about the mechanisms of action for available treatments, in order to refine and improve short- and long-term therapeutic strategies for a highly debilitating and often lifelong disorder.

Timeline

Start
2007-01
Primary completion
2010-08
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 20 mg